Jamieson Wellness (TSE:JWEL – Get Free Report) was downgraded by equities research analysts at TD from a “buy” rating to a “hold” rating in a research note issued on Monday,BayStreet.CA reports. They currently have a C$49.00 price objective on the stock, up from their previous price objective of C$48.00. TD’s price target indicates a potential upside of 7.55% from the stock’s current price.
A number of other equities analysts also recently issued reports on the company. Canadian Imperial Bank of Commerce downgraded Jamieson Wellness from an “outperformer” rating to a “tender” rating and increased their price target for the stock from C$44.00 to C$45.75 in a research report on Friday. Stifel Nicolaus downgraded Jamieson Wellness from a “buy” rating to a “hold” rating and upped their target price for the stock from C$45.00 to C$45.75 in a research note on Friday. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of C$46.43.
Read Our Latest Stock Report on JWEL
Jamieson Wellness Stock Performance
Jamieson Wellness (TSE:JWEL – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. The business had revenue of C$233.84 million for the quarter. On average, analysts expect that Jamieson Wellness will post 2.1438892 earnings per share for the current year.
Jamieson Wellness Company Profile
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.
Read More
- Five stocks we like better than Jamieson Wellness
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
